Scopus
YÖKSİS Eşleşti
Evaluation of contraception methods in chronic myeloid leukemia patients: A Turkish multicenter study
Journal of Oncology Pharmacy Practice · Ocak 2024
YÖKSİS Kayıtları
Evaluation of contraception methods in chronic myeloid leukemia patients: A Turkish multicenter study
Journal of Oncology Pharmacy Practice · 2024 SCI-Expanded
PROFESÖR RAFİYE ÇİFTÇİLER →
Makale Bilgileri
DergiJournal of Oncology Pharmacy Practice
Yayın TarihiOcak 2024
Scopus ID2-s2.0-85203025301
Özet
Background and Aim: Chronic myeloid leukemia (CML) incidence has recently increased in younger individuals. With time, given the nature of the disease and available therapies, as well as the existing paucity and inconsistency of advice, worries about fertility have surfaced. With all these clear unknowns, we designed this study to raise awareness among both physicians and CML patients about whether male and female patients of childbearing age were using contraception at the time of diagnosis, and if so, which methods they were using. In this context, this study aimed to evaluate the contraception methods in patients with CML. Materials and Methods: Eighteen centres from Turkey participated in the study. Male and female patients of childbearing age diagnosed with chronic and accelerated phase CML between the years 2000 and 2024 were evaluated retrospectively. Results: Of the two hundred and thirty-two patients included, one hundred and twenty-five (53.9%) of these patients were female and 107 (46.1%) were male. At diagnosis, all female patients were in the childbearing age, and male patients were sexually active. The median age at diagnosis of the patients was 38 (range, 18–77) years. Eighty-six (68.8%) female patients were using any contraception method, while this was 53.2% (n = 57) among male patients. Conclusion: In conclusion, since CML patients are diagnosed at an earlier age and the desire of these patients to have children, adequate information and evaluation should be provided regarding fertility and contraception issues, especially in female patients, from the moment of diagnosis.
Yazarlar (21)
1
Rafiye Çiftçiler
ORCID: 0000-0001-5687-8531
2
Cem Selim
ORCID: 0000-0002-2717-8306
3
Melda Cömert
4
Haydar Zengin
5
Yıldız İpek
6
Vildan Gürsoy
7
Esra Yıldızhan
8
Abdülkerim Yıldız
ORCID: 0000-0002-9596-4042
9
Samet Yaman
10
Tayfun Elibol
11
Serkan Güven
12
Eren Arslan Davulcu
13
Deniz Özmen
14
Atakan Tekinalp
ORCID: 0000-0001-7937-4045
15
Zehra Narlı Özdemir
16
Mehmet Baysal
ORCID: 0000-0001-7681-4623
17
Sinan Mersin
18
Zeynep Güven
ORCID: 0000-0003-1600-9731
19
İbrahim Ethem Pınar
20
Serhat Çelik
ORCID: 0000-0002-1052-9800
21
Ahmet Emre Eşkazan
Anahtar Kelimeler
adolescent & young adult
AYA
chronic myeloid leukemia
CML
contraception
pregnancy
tyrosine kinase inhibitors
Kurumlar
Adana City Hospital
Adana Turkey
Ali Osman Sönmez Oncology Hospital
Bursa Turkey
Bursa City Hospital
Bursa Türkiye
Goztepe Prof. Dr. Suleyman Yalcin City Hospital
Istanbul Turkey
Gülhane Eğitim ve Araştırma Hastanesi
Ankara Turkey
Hitit University
Corum Turkey
Isparta City Hospital
Isparta Turkey
İstanbul University-Cerrahpaşa Cerrahpaşa Faculty of Medicine
Istanbul Turkey
Izmir City Hospital
Izmir Turkey
Kartal Dr. Lütfi Kırdar City Hospital
Istanbul Türkiye
Kayseri City Hospital
Kayseri Turkey
Mehmet Akif Ersoy State Hospital
Canakkale Turkey
Mehmet Akif Inan Training and Research Hospital
Sanliurfa Turkey
Muğla Sıtkı Koçman Üniversitesi
Mugla Turkey
Necmettin Erbakan Üniversitesi
Meram Turkey
Selçuk Tip Fakültesi
Konya Turkey
University of Health Sciences
Istanbul Turkey
Yenimahalle Training and Research Hospital
Ankara Turkey